Title

Innovative peptides against cancer and pathogenic bacteria, with advances in science, biopharmaceutical drug development, product market targeting, training, and communication.

Acronym

INPACT

Funding Agency

European Commission

Funding Programme

Horizon 2020

Call / Topic

H2020-MSCA-RISE-2014

Project Reference

644167

Start Date and duration

2015.02.01 (48 months)

Total investment

EUR 1 390 500 (EU contribution: EUR 850 500)

Project Coordinator

Miguel Castanho (Instituto de Medicina Molecular João Lobo Antunes (iMM), Portugal)

Project Beneficiaries

– Instituto de Medicina Molecular João Lobo Antunes (iMM), Portugal
– Universidad Pompeu Fabra (UPF), Spain
– Universidad de Navarra (IESE Business
School), Spain
– Technophage, Portugal
– Centro Atlantico del Medicamento
(CEAMED), Spain
– ProteoDesign, Spain

Project Partners

– Universidade Federal do Rio de Janeiro (UFRJ), Brazil
– University of Queensland (UQ), Australia
– Stanford University (SU), United Kingdom
– Instituto Ciência Hoje (ICH), Brazil

CORDIS

INPACT
(https://cordis.europa.eu/project/rcn/196622/factsheet/en)